SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001600620-24-000085
Filing Date
2024-06-04
Accepted
2024-06-04 17:25:39
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14alsresponsecombined.htm DEFA14A 38134
2 selceresponsepressreleas001.jpg GRAPHIC 227557
3 selceresponsepressreleas002.jpg GRAPHIC 242600
4 selceresponsepressreleas003.jpg GRAPHIC 212711
5 selceresponsepressreleas004.jpg GRAPHIC 322628
  Complete submission text file 0001600620-24-000085.txt   1424466
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36421 | Film No.: 241019572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)